Soyasapogenol B Composition for Enhanced Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current soyasaponin compositions lack improved absorption rates, particularly for soyasaponin group B, which limits their bioactivity and efficacy in applications such as blood glucose level suppression and cholesterol lowering.
Innovation Solution
A composition comprising soyasapogenol B and 3-O-D-glucuronopyranosyl soyasapogenol B, produced through partial acid decomposition of soyasaponin group B glycoside, with a weight ratio of 0.001 to 10, enhancing absorption and bioavailability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If soyasaponin group B glycoside is used, then bioactivity such as blood glucose suppression and cholesterol lowering is achieved, but absorption rate is insufficient
Solution Approach 1:
The soyasaponin group B glycoside is segmented into two components: soyasapogenol B (aglycone) and 3-O-D-glucuronopyranosyl soyasapogenol B (glycoside). This segmentation allows the composition to leverage both the high absorption of the aglycone and the high bioactivity of the glycoside, resolving the contradiction between absorption rate and bioactivity.
Solution Approach 2:
The invention changes the chemical structure parameter by partially removing sugar chain residues from soyasaponin group B glycoside through acid decomposition. This parameter change transforms the molecule from a glycoside form (lower absorption) to a mixed composition containing aglycone (higher absorption), while maintaining the bioactive properties.
2Reliability
If soyasaponin group B glycoside is used, then therapeutic effects are achieved, but higher doses are required due to low absorption
Solution Approach 1:
By segmenting the soyasaponin group B glycoside into soyasapogenol B and 3-O-D-glucuronopyranosyl soyasapogenol B, the invention creates a composition where the aglycone portion enhances absorption, allowing therapeutic effects to be achieved at lower overall doses while maintaining the required therapeutic effect.
Solution Approach 2:
The invention creates a composite material consisting of soyasapogenol B and 3-O-D-glucuronopyranosyl soyasapogenol B in a specific weight ratio (0.001 to 10). This composite leverages the complementary properties of both components: high absorption of the aglycone and high bioactivity of the glycoside, enabling lower dosing while achieving therapeutic effects.
3Productivity
If complete acid decomposition is performed to obtain soyasapogenol B, then absorption is improved, but 3-O-D-glucuronopyranosyl soyasapogenol B is not detected
Solution Approach 1:
Instead of performing complete acid decomposition, the invention uses partial acid decomposition to remove only part of the sugar chain residues. This partial action produces a mixed composition containing both soyasapogenol B and 3-O-D-glucuronopyranosyl soyasapogenol B, maintaining the bioactivity provided by the glycoside while improving absorption through the presence of the aglycone.
Solution Approach 2:
The invention controls the degree of acid decomposition to achieve a specific parameter range for the weight ratio of 3-O-D-glucuronopyranosyl soyasapogenol B to soyasapogenol B (0.001 to 10). This parameter control ensures optimal balance between absorption (from aglycone) and bioactivity (from glycoside).
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition exhibits higher absorption and bioactivity of soyasapogenol B, allowing for effective suppression of blood glucose and cholesterol levels with lower doses, making it suitable for medical, food, and cosmetic applications.
Implementation Method 1
produced through partial acid decomposition of soyasaponin group B glycoside
Data Source
AI summary
A soy saponin composition is provided high bodily absorption characteristics. In an embodiment, a soyasapogenol composition comprises soyasapogenol B and 3-O-D-glucuronopyranosyl soyasapogenol B. The weight ratio (B/A) of the 3-O-D-glucuronopyranosyl soyasapogenol B to the soyasapogenol B is in the range of 0.001-10. The composition can be produced by partial decomposition of a sugar chain residue of a soy saponin B group glycoside utilizing an acid.